Immunologic Mechanisms and Engineering Objectives: Case Study of Anti-PD-L1 x IL-15

PEGS Europe Virtual – November 11, 2020
Program: Advancing Bispecifics and Combination Therapy to the Clinic

Daniel S. Chen, MD, PhD, Chief Medical Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

PEGS EU 2020 IL15 DSChen

Posted in publications.